Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 17Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 0 | 0% | $ 53K |
| 3/31/2025 | $ 0 | 0% | $ 58K |
| 12/31/2024 | $ 0 | 0% | $ 61K |
| 9/30/2024 | $ 0 | 0% | $ 63K |
| 6/30/2024 | $ 0 | 0% | $ 54K |
| 3/31/2024 | $ 0 | 0% | $ 68K |
| 12/31/2023 | $ 0 | 0% | $ 130K |
| 9/30/2023 | $ 0 | 0% | $ 48.5M |
| 6/30/2023 | $ 0 | 0% | $ 48.48M |
| 3/31/2023 | $ 0 | 0% | $ 84.19M |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average Int. Exp. % has been 0%.
- The median Int. Exp. % for LYELL IMMUNOPHARMA INC during this period was 0%
- LYELL IMMUNOPHARMA INC reached its highest Int. Exp. % over the past 5 years at 0%.
- The lowest Int. Exp. % recorded by LYELL IMMUNOPHARMA INC in the same timeframe 0%
LYELL IMMUNOPHARMA INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for LYELL IMMUNOPHARMA INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 7.76M ]
(=) Int. Exp. % [ 0% ] LYEL - Interest Expense Margin, Last 5 years
0%
Minimum
Dec 31, 2020
0%
Maximum
Dec 31, 2020
0%
Average
0%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |